[Blood preparations in current transfusiology].

[Effect of transfusions of albumin and protein from the placental and abortion serum on various biochemical indicators of blood of patients with disorders of the pituitary-adrenal system]. Probl Gematol Pereliv Krovi (1977) 0.75

[Distribution of the iron-containing preparation feral in the animal body]. Probl Gematol Pereliv Krovi (1982) 0.75

[Some principle characteristics of chronic lympholeukemia]. Probl Gematol Pereliv Krovi (1970) 0.75

[The initial trial of the clinical use of FK-1 glue in surgical interventions]. Vestn Khir Im I I Grek (2000) 0.75

[Current tactics in the treatment of chronic lympholeukemia]. Probl Gematol Pereliv Krovi (1971) 0.75

[Technological equipment and the automation of plasma fractionation processes]. Probl Gematol Pereliv Krovi (1981) 0.75

[Protein and its use in protein deficiency states and protein-deficient anemias]. Probl Gematol Pereliv Krovi (1972) 0.75

[Experimental study of the protective activity of the plasma from donors immunized with an enterobacterial vaccine]. Gematol Transfuziol (1986) 0.75

Vaccines against Pseudomonas aeruginosa infection: 2. Clinico-immunological investigations. Vaccine (1985) 0.75

[Conditions for obtaining hemostatic preparations from donor plasma]. Gematol Transfuziol (1989) 0.75

[The fractional composition of immunoglobulin preparations studied by gel filtration on different carriers and by high-pressure liquid chromatography]. Zh Mikrobiol Epidemiol Immunobiol (1992) 0.75

[Donor immunization with an inactivated concentrated purified vaccine against tick-borne encephalitis to obtain immune blood preparations]. Vopr Virusol (1984) 0.75

Clinico-immunological trials of Pseudomonas aeruginosa vaccine. Vaccine (1991) 0.75

[Optimal industrial conditions for the production of antistaphylococcal immunoglobulin]. Gematol Transfuziol (1990) 0.75

[Stable pasteurized plasma proteins and the sources of their extraction]. Probl Gematol Pereliv Krovi (1967) 0.75

[Prospects for the development of an antiproteinase agent on the basis of human alpha 2-macroglobulin]. Probl Gematol Pereliv Krovi (1982) 0.75

[Effect of ethyl alcohol on the conformation of the molecules of human serum albumin in solution under heat and acid treatment]. Probl Gematol Pereliv Krovi (1972) 0.75

[Therapeutic effectiveness of 20% placental albumin in liver cirrhosis]. Probl Gematol Pereliv Krovi (1978) 0.75

[On the 70th birthday of N.G. Kartashevskiĭ]. Probl Gematol Pereliv Krovi (1976) 0.75

[Methylation of DNA cytosine in lymphocytes of healthy subjects and in chronic lympholeukosis]. Biull Eksp Biol Med (1973) 0.75

[Biologically active therapeutic preparations with polyvalent action based on complexes of human serum proteins with metals]. Probl Gematol Pereliv Krovi (1982) 0.75

[The immunological response in volunteer donors immunized with a Pseudomonas vaccine]. Zh Mikrobiol Epidemiol Immunobiol (1991) 0.75

[Experimental study of a laboratory series of gamma globulin]. Vestn Dermatol Venerol (1986) 0.75

[Study of biologically active substances in preparations from placental and abortion blood serum]. Probl Gematol Pereliv Krovi (1977) 0.75

[Comparative study of the quality of domestic albumin solution and foreign analogs]. Gematol Transfuziol (1993) 0.75

[Standardization of albumin preparations]. Gematol Transfuziol (1987) 0.75

[Study of optimal conditions of purifying and sterilizing filtration of a stabile pasteurized solution of plasma proteins]. Probl Gematol Pereliv Krovi (1968) 0.75

[Blood substitutes]. Arch Pathol Lab Med (1975) 0.75

[Organizational problems in the production of therapeutic preparations using donors' blood]. Sov Med (1983) 0.75